Fundraising Fox
Praxis
NASDAQ: PRAXBoston, US · Founded 2015 · 293 employees on LinkedIn · 14 known investors
Find your way into Praxis
833 people in our graph can introduce you to the Praxis team.
Sign up to see every warm intro you have to Praxis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Praxis team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy. Its portfolio uses both small molecule (Cerebrum) and antisense oligonucleotide (Solidus) platforms informed by human genetics and translational science.</parameter> <parameter name="founders">[]
Founders & leadership
Praxis was founded in 2015 by Steve Petrou.
Board
Investors · 14
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
How we know: OCV Partners's portfolio page · Not right? Tell us
How we know: funding news · finance.yahoo.com · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
How we know: funding news · finance.yahoo.com · Not right? Tell us
How we know: the S-1 prospectus · board seat on SEC Form D · Not right? Tell us
Funding
SEC filings, press & company announcements$31.9M disclosed across 3 of 5 rounds · 2016–2024
- Undisclosed amountSeries AMar 2022
Alameda Research, Apollo Projects, Paradigm Capital, Robot Ventures, Three Arrows Capital, Winklevoss Capital
Source ↗
▶$10MraisedJun 2019 · 5 investors · PharmaceuticalsRule 506(b)
- KIRAN REDDYExecutive Officer, Director
- NICHOLAS GALAKATOSDirector
- THOMAS DYRBERGDirector
- STEFAN VITOROVICDirector
- STUART CHAFFEEExecutive Officer
- WILLIAM YOUNGDirector
- PAUL MEDEIROSDirector
- ARI BRETTMANDirector
- GREGORY NORDENDirector
- ALFRED SANDROCKDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$18.8MraisedMar 2018 · 6 investors · PharmaceuticalsRule 506(b)
- William D. YoungDirector
- Alfred Sandrock, Jr.Director
- Nicholas G. GalakatosDirector
- Stuart ChaffeeExecutive Officer
- Kiran ReddyExecutive Officer, Director
- Offering amount
- $46.4M
- Amount sold
- $18.8M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.1MraisedNov 2016 · 2 investors · PharmaceuticalsRule 506(b)
- Nicholas G. GalakatosDirector
- Kiran ReddyExecutive Officer, Director
- Offering amount
- $7.7M
- Amount sold
- $3.1M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
3 people who came through Praxis went on to found or lead other companies.
Frequently asked questions
- What does Praxis do?
- Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy. Its portfolio uses both small molecule (Cerebrum) and antisense oligonucleotide (Solidus) platforms informed by human genetics and translational science.</parameter> <parameter name="founders">[]
- Who founded Praxis?
- Praxis was founded by Steve Petrou in 2015.
- Who are Praxis's investors?
- Praxis's investors include Avoro Capital Advisors, Capria Ventures, OCV Partners, Alameda Research, APOLLO PROJECTS, Blackstone, Clarus Ventures, Norwest Venture Partners and 6 more.
- How much funding has Praxis raised?
- Praxis has disclosed $31.9M raised across 3 of its 5 known rounds.
- Where is Praxis headquartered?
- Praxis is headquartered in Boston, US.